Cargando…

Innovations in the Assessment of Primary and Secondary Raynaud’s Phenomenon

Objectives: Raynaud’s phenomenon (RP) is characterized by intense vasospasm of the digital arteries that causes characteristic color changes in fingers. There are two main types of RP: Primary RP (PRP) and Secondary RP (SRP). PRP is a benign condition. Whilst SRP is associated with several connectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruaro, Barbara, Smith, Vanessa, Sulli, Alberto, Pizzorni, Carmen, Tardito, Samuele, Patané, Massimo, Paolino, Sabrina, Cutolo, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495407/ https://www.ncbi.nlm.nih.gov/pubmed/31073287 http://dx.doi.org/10.3389/fphar.2019.00360

Ejemplares similares

Aminaphtone Efficacy in Primary and Secondary Raynaud’s Phenomenon: A Feasibility Study
por: Ruaro, Barbara, et al.
Publicado: (2019)

Understanding the value of non-specific abnormal capillary dilations in presence of Raynaud’s phenomenon: a detailed capillaroscopic analysis
por: Pacini, Greta, et al.
Publicado: (2022)

Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
por: Cutolo, Maurizio, et al.
Publicado: (2021)

Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity
por: Cutolo, Maurizio, et al.
Publicado: (2023)

CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients
por: Cutolo, Maurizio, et al.
Publicado: (2021)

Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments
por: Trombetta, Amelia Chiara, et al.
Publicado: (2017)

Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2015)

Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients
por: Ruaro, Barbara, et al.
Publicado: (2020)

Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages
por: Soldano, Stefano, et al.
Publicado: (2016)

Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages
por: Soldano, Stefano, et al.
Publicado: (2017)

A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement
por: Trombetta, Amelia Chiara, et al.
Publicado: (2018)

Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis
por: Sulli, A., et al.
Publicado: (2017)

Capillaroscopy as an Outcome Measure for Clinical Trials on the Peripheral Vasculopathy in SSc—Is It Useful?
por: Cutolo, Maurizio, et al.
Publicado: (2010)

Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay
por: Cutolo, Maurizio, et al.
Publicado: (2018)

Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients
por: Paolino, Sabrina, et al.
Publicado: (2020)

Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic
por: Gotelli, Emanuele, et al.
Publicado: (2022)

The dichotomy of glucocorticosteroid treatment in immune-inflammatory rheumatic diseases: an evidence-based perspective and insights from clinical practice
por: Hysa, Elvis, et al.
Publicado: (2023)

Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023)

Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms
por: Fardoun, Manal M., et al.
Publicado: (2016)

Vitamin D and Lung Outcomes in Elderly COVID-19 Patients
por: Sulli, Alberto, et al.
Publicado: (2021)

Understanding the Immune-Endocrine Effects of Vitamin D in SARS-CoV-2 Infection: A Role in Protecting against Neurodamage
por: Gotelli, Emanuele, et al.
Publicado: (2023)

A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions
por: Gotelli, Emanuele, et al.
Publicado: (2023)

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?
por: Paolino, Sabrina, et al.
Publicado: (2017)

Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
por: Hysa, Elvis, et al.
Publicado: (2023)

Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011)

Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)

Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors
por: Sulli, Alberto, et al.
Publicado: (2022)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts
por: Cutolo, Maurizio, et al.
Publicado: (2018)

G protein estrogen receptor as a potential therapeutic target in Raynaud’s phenomenon
por: Fardoun, Manal, et al.
Publicado: (2022)

Interactions between microbiota, diet/nutrients and immune/inflammatory response in rheumatic diseases: focus on rheumatoid arthritis
por: Paolino, Sabrina, et al.
Publicado: (2019)

Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey
por: Paolino, Sabrina, et al.
Publicado: (2021)

Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis
por: Cattelan, Francesco, et al.
Publicado: (2022)

Local hyperhemia to heating is impaired in secondary Raynaud's phenomenon
por: Boignard, Aude, et al.
Publicado: (2005)

Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging
por: Hysa, Elvis, et al.
Publicado: (2023)

Plasma Homocysteine is Not Related to the Severity of Microangiopathy in Secondary Raynaud Phenomenon
por: Jacomella, Vincenzo, et al.
Publicado: (2011)

Koilonychia secondary to Raynaud's phenomenon: A rare co-occurrence
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
por: Manickam, Agaath Hedina, et al.
Publicado: (2021)

Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)

Raynaud's phenomenon in pediatric age
por: Tavares, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d27b66ugilupl0mgs8pgbmaj4d